Insider Selling: Inspire Medical Systems (NASDAQ:INSP) CFO Sells $267,440.00 in Stock

Inspire Medical Systems (NASDAQ:INSP) CFO Richard Buchholz sold 4,000 shares of the company’s stock in a transaction on Monday, August 19th. The shares were sold at an average price of $66.86, for a total value of $267,440.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Richard Buchholz also recently made the following trade(s):

  • On Tuesday, July 16th, Richard Buchholz sold 4,000 shares of Inspire Medical Systems stock. The shares were sold at an average price of $68.34, for a total value of $273,360.00.
  • On Monday, June 17th, Richard Buchholz sold 4,000 shares of Inspire Medical Systems stock. The shares were sold at an average price of $56.37, for a total value of $225,480.00.

Shares of INSP opened at $65.51 on Friday. The business’s 50-day moving average is $66.36 and its two-hundred day moving average is $57.95. Inspire Medical Systems has a fifty-two week low of $35.43 and a fifty-two week high of $69.71.

Inspire Medical Systems (NASDAQ:INSP) last announced its quarterly earnings results on Tuesday, August 6th. The company reported ($0.32) earnings per share for the quarter, topping the consensus estimate of ($0.45) by $0.13. The company had revenue of $18.03 million for the quarter, compared to analyst estimates of $21.26 million. Inspire Medical Systems’s revenue for the quarter was up 64.9% on a year-over-year basis. During the same period in the prior year, the business posted ($0.43) earnings per share.

Several equities analysts recently issued reports on the company. Zacks Investment Research raised Inspire Medical Systems from a “sell” rating to a “hold” rating in a research report on Saturday, August 3rd. Bank of America reaffirmed a “neutral” rating and set a $75.00 price target (up from $65.00) on shares of Inspire Medical Systems in a research report on Monday, July 8th. One research analyst has rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus price target of $57.20.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Morgan Stanley grew its position in Inspire Medical Systems by 3.6% during the 2nd quarter. Morgan Stanley now owns 1,441,080 shares of the company’s stock worth $87,401,000 after purchasing an additional 50,166 shares during the period. BlackRock Inc. grew its position in Inspire Medical Systems by 43.5% during the 2nd quarter. BlackRock Inc. now owns 1,406,301 shares of the company’s stock worth $85,293,000 after purchasing an additional 426,425 shares during the period. William Blair Investment Management LLC grew its position in Inspire Medical Systems by 5.9% during the 2nd quarter. William Blair Investment Management LLC now owns 1,160,880 shares of the company’s stock worth $70,407,000 after purchasing an additional 64,785 shares during the period. Invesco Ltd. grew its position in Inspire Medical Systems by 279.8% during the 2nd quarter. Invesco Ltd. now owns 965,710 shares of the company’s stock worth $58,570,000 after purchasing an additional 711,435 shares during the period. Finally, Vanguard Group Inc. grew its position in Inspire Medical Systems by 12.8% during the 2nd quarter. Vanguard Group Inc. now owns 795,694 shares of the company’s stock worth $48,258,000 after purchasing an additional 90,413 shares during the period.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

Further Reading: Return on Equity (ROE)

Insider Buying and Selling by Quarter for Inspire Medical Systems (NASDAQ:INSP)

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.